|
시장보고서
상품코드
1812436
단백질 치료제 시장 : 제품 유형별, 용도별, 기술별, 투여 경로별, 최종 사용자별Protein Therapeutics Market, By Product Type, By Application, By Technology, By Route of Administration,By End User: Hospitals, Clinics, Research Laboratories, and Pharmaceutical and Biotechnology Companies |
||||||
단백질 치료제 시장은 2025년에 3,458억 2,000만 달러로 추정되고, 2032년까지 5,589억 5,000만 달러에 이를 것으로 예측되며, 2025-2032년까지 연평균 성장률(CAGR) 7.1%로 성장할 전망입니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 매출(2025년) | 3,458억 2,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2020-2024년 |
| 예측 기간(2025-2032년)의 CAGR : | 7.10% | 금액 예측(2032년) | 5,589억 5,000만 달러 |
세계의 단백질 치료 시장은 제약 산업 내에서 급속히 진화하는 부문으로, 다양한 질병 및 의학적 상태를 치료하기 위해 설계된 치료용 단백질의 개발 및 상용화가 특징입니다. 단백질 치료 시장은 단일클론 항체, 재조합 단백질, 백신, 혈액 요인, 효소 치료제 등 인체의 자연적인 단백질 메커니즘을 치료적 개입에 활용하는 다양한 생물학적 제제를 포함됩니다.
이 시장은 생명공학의 발전, 단백질 구조-기능 관계에 대한 이해도 향상, 그리고 복잡한 생물학적 분자의 대규모 생산을 가능하게 하는 정교한 제조 공정에 의해 촉진된 전례 없는 성장을 경험해 왔습니다. 치료적 용도 분야는 종양학, 자가면역 질환, 대사성 질환, 감염병, 희귀 유전 질환 등 다양한 질환 영역에 걸쳐 있어, 단백질 치료 시장은 최근 의학에서 가장 다재다능하고 유망한 부문 중 하나로 자리매김하고 있습니다.
만성 질환의 증가, 전 세계 인구 고령화, 맞춤형 의약품 접근법에 대한 수요 증가로 단백질 치료 시장은 의약품, 바이오테크 기업, 연구 기관으로부터 상당한 대규모 투자를 유치하며 미래 의료 솔루션과 의학 혁신 전략의 핵심 컴포넌트로 자리매김하고 있습니다.
시장 역학
세계의 단백질 치료 시장은 주로 다음과 같은 주요 요인들에 의해 촉진되며, 이들이 종합적으로 강력한 성장 궤도를 이끌고 있습니다. 암, 당뇨병, 자가면역 질환, 심혈관 질환 등 만성 질환의 증가하는 유병률은 기존 소분자 약물 대비 우수한 효능과 감소된 부작용을 제공하는 혁신적인 단백질 기반 치료제에 대한 상당한 수요를 창출합니다. 재조합 DNA 기술, 단백질 공학, 생물공정 능력의 기술적 발전은 복잡한 단백질 치료제의 개발 및 제조 효율성을 크게 향상시켰으며, 규제 체계는 획기적인 치료법에 대한 신속한 승인 절차를 뒷받침하도록 진화했습니다.
세계적으로 고령 인구가 증가함에 따라 노화 관련 질환에 대한 효과적인 치료법 필요성이 증대되고 있으며, 맞춤형 의학의 이해가 확대됨에 따라 표적 단백질 치료제에 대한 수요가 촉진되고 있습니다. 그러나 시장에는 극도로 높은 연구개발 비용, 전문 시설과 전문성을 요구하는 복잡한 제조 공정, 개발 기간을 연장시키는 엄격한 규제 요건, 단백질 안정성, 저장 및 전달과 관련된 상당한 과제 등 주목할 만한 제약 요인들이 존재합니다.
블록버스터 단백질 의약품의 특허 만료는 바이오시밀러 경쟁으로 이어져 원개발사의 수익 흐름에 잠재적 영향을 미칠 수 있습니다. 이러한 도전에도 불구하고, 신흥 시장 확대, 항체-약물 복합체 및 이중특이성 항체와 같은 향후 단백질 공학 기술 개발, 미충족 의료 수요가 높은 희귀질환 치료 분야에서의 용도 확대, 치료 효과 및 환자 관리를 향상시키기 위해 단백질 치료제를 다른 치료 모달리티와 통합하는 병용 요법의 증가하는 채택을 통해 상당한 기회가 존재합니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 단백질 치료제 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 매개변수를 기반으로 전 세계의 단백질 치료제 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 단백질 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 단백질 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시 및 승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 단백질 치료제 시장, 제품 유형별(2020-2032년)
- 단일클론항체(mAbs)
- 인슐린 유사체
- 재조합 단백질
- 융합 단백질
- 혈액 인자
- 인간 성장 호르몬(hGH)
- 난포자극호르몬(FSH)
- 인터페론
- 기타(예 : 에리스로포이에틴 등)
제5장 세계의 단백질 치료제 시장, 용도별(2020-2032년)
- 암 치료
- 자가면역질환
- 감염증
- 혈우병 및 응고장애
- 당뇨병
- 심혈관 질환
- 신경질환
- 유전성 질환
제6장 세계의 단백질 치료제 시장, 기술별(2020-2032년)
- 재조합 DNA 기술
- 세포 기반 기술
- 하이브리도마 기술
- 기타(유전자 편집, 트랜스펙션)
제7장 세계의 단백질 치료제 시장, 투여 경로별(2020-2032년)
- 비경구(주사제)
- 경구
- 기타(국소, 비강)
제8장 세계의 단백질 치료제 시장, 최종 사용자별(2020-2032년)
- 병원
- 클리닉
- 연구소
- 제약 및 생명공학 기업
제9장 세계의 단백질 치료제 시장, 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제10장 경쟁 구도
- Amgen Inc
- Thermo Fisher Scientific Inc
- Genentech(Roche)
- AbbVie Inc
- Novo Nordisk
- Merck and Co.
- Johnson and Johnson
- Eli Lilly and Company
- Pfizer Inc
- Regeneron Pharmaceuticals
- Biogen Inc
- AstraZeneca
- Gilead Sciences
- Bristol-Myers Squibb
- Aurigene Pharmaceutical Services Ltd.
제11장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- 일관된 기회 지도
제12장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Protein Therapeutics Market is estimated to be valued at USD 345.82 Bn in 2025 and is expected to reach USD 558.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 345.82 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.10% | 2032 Value Projection: | USD 558.95 Bn |
The global protein therapeutics market represents a rapidly evolving segment within the pharmaceutical industry, characterized by the development and commercialization of therapeutic proteins designed to treat various diseases and medical conditions. Protein therapeutics encompass a diverse range of biological molecules including monoclonal antibodies, recombinant proteins, vaccines, blood factors, and enzyme therapies that leverage the body's natural protein mechanisms for therapeutic intervention.
This market has experienced unprecedented growth driven by advancements in biotechnology, improved understanding of protein structure-function relationships, and sophisticated manufacturing processes that enable large-scale production of complex biological molecules. The therapeutic applications span across multiple disease areas including oncology, autoimmune disorders, metabolic diseases, infectious diseases, and rare genetic conditions, making protein therapeutics one of the most versatile and promising segments in modern medicine.
With increasing prevalence of chronic diseases, aging populations worldwide, and growing demand for personalized medicine approaches, the protein therapeutics market continues to attract significant investment from pharmaceutical companies, biotechnology firms, and research institutions, positioning it as a critical component of future healthcare solutions and medical innovation strategies.
Market Dynamics
The global protein therapeutics market is primarily driven by several key factors that collectively propel its robust growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions creates substantial demand for innovative protein-based therapeutic solutions that offer superior efficacy and reduced side effects compared to traditional small-molecule drugs. Technological advancements in recombinant DNA technology, protein engineering, and bioprocessing capabilities have significantly enhanced the development and manufacturing efficiency of complex protein therapeutics, while regulatory frameworks have evolved to support faster approval pathways for breakthrough therapies.
The growing aging population worldwide amplifies the need for effective treatments for age-related diseases, and the expanding understanding of personalized medicine drives demand for targeted protein therapies. However, the market faces notable restraints including extremely high research and development costs, complex manufacturing processes requiring specialized facilities and expertise, stringent regulatory requirements that extend development timelines, and significant challenges related to protein stability, storage, and delivery.
Patent expiration of blockbuster protein drugs leads to biosimilar competition, potentially impacting revenue streams for original manufacturers. Despite these challenges, substantial opportunities exist through emerging markets expansion, development of next-generation protein engineering technologies such as antibody-drug conjugates and bispecific antibodies, increasing applications in rare disease treatments where unmet medical needs remain high, and growing adoption of combination therapies that integrate protein therapeutics with other treatment modalities to enhance therapeutic outcomes and patient care.
Key Features of the Study
- This report provides in-depth analysis of the global protein therapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global protein therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc, Thermo Fisher Scientific Inc, Genentech (Roche), AbbVie Inc, Novo Nordisk, Merck and Co., Johnson and Johnson, Eli Lilly and Company, Pfizer Inc, Regeneron Pharmaceuticals, Biogen Inc, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb, and Aurigene Pharmaceutical Services Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global protein therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein therapeutics market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies (mAbs)
- Insulin and Analogues
- Recombinant Proteins
- Fusion Proteins
- Blood Factors
- Human Growth Hormones (hGH)
- Follicle-Stimulating Hormone (FSH)
- Interferons
- Others (e.g., Erythropoietin, etc.)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cancer Treatment
- Autoimmune Diseases
- Infectious Diseases
- Hemophilia and Coagulation Disorders
- Diabetes
- Cardiovascular Diseases
- Neurological Disorders
- Genetic Disorders
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Recombinant DNA Technology
- Cell-Based Technology
- Hybridoma Technology
- Others (Gene Editing, Transfection)
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Parenteral (Injectables)
- Oral
- Others (Topical, Nasal)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Clinics
- Research Laboratories
- Pharmaceutical and Biotechnology Companies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc
- Thermo Fisher Scientific Inc
- Genentech (Roche)
- AbbVie Inc
- Novo Nordisk
- Merck and Co.
- Johnson and Johnson
- Eli Lilly and Company
- Pfizer Inc
- Regeneron Pharmaceuticals
- Biogen Inc
- AstraZeneca
- Gilead Sciences
- Bristol-Myers Squibb
- Aurigene Pharmaceutical Services Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Protein Therapeutics Market, By Product Type
- Global Protein Therapeutics Market, By Application
- Global Protein Therapeutics Market, By Technology
- Global Protein Therapeutics Market, By Route of Administration
- Global Protein Therapeutics Market, By End User
- Global Protein Therapeutics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Protein Therapeutics Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Insulin and Analogues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fusion Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Human Growth Hormones (hGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Follicle-Stimulating Hormone (FSH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Interferons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (e.g., Erythropoietin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Protein Therapeutics Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hemophilia and Coagulation Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Protein Therapeutics Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Recombinant DNA Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell-Based Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hybridoma Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Gene Editing, Transfection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Protein Therapeutics Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Parenteral (Injectables)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Topical, Nasal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Protein Therapeutics Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Protein Therapeutics Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive landscape
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genentech (Roche)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck and Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurigene Pharmaceutical Services Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
